Nan Fung Group Holdings Ltd 13F holdings
Nan Fung Group Holdings Ltd reported 25 positions with a total reported value of $131.5M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: MPLT MAPLIGHT THERAPEUTICS INC (26.5%), LBRX LB PHARMACEUTICALS INC (15.6%), EVMN EVOMMUNE INC (14.6%), CYBIN INC (5.0%), INCY INCYTE CORP (4.6%). Against 2026-03-31 it opened 1 new position and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Nan Fung Group Holdings Ltd files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
25 largest of 25 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| MPLT MAPLIGHT THERAPEUTICS INC | 971,253 | $34.8M | 26.5% |
| LBRX LB PHARMACEUTICALS INC | 630,657 | $20.5M | 15.6% |
| EVMN EVOMMUNE INC | 1,441,032 | $19.2M | 14.6% |
| CYBIN INC | 987,222 | $6.5M | 5.0% |
| INCY INCYTE CORP | 53,742 | $6.1M | 4.6% |
| RYTM RHYTHM PHARMACEUTICALS INC | 49,120 | $5.5M | 4.1% |
| ONC BEONE MEDICINES LTD | 15,722 | $4.5M | 3.4% |
| OCS OCULIS HOLDING AG | 300,565 | $4.2M | 3.2% |
| ASND ASCENDIS PHARMA A/S | 13,600 | $3.6M | 2.8% |
| RVMD REVOLUTION MEDICINES INC | 19,253 | $3.6M | 2.7% |
| KYMR KYMERA THERAPEUTICS INC | 30,875 | $3.5M | 2.7% |
| MDGL MADRIGAL PHARMACEUTICALS INC | 5,672 | $3.0M | 2.3% |
| CELC CELCUITY INC | 28,300 | $3.0M | 2.3% |
| ACAD ACADIA PHARMACEUTICALS INC | 102,984 | $2.6M | 2.0% |
| ARGX ARGENX SE | 2,800 | $2.6M | 2.0% |
| RXRX RECURSION PHARMACEUTICALS IN | 595,287 | $2.2M | 1.7% |
| PCOR PROCORE TECHNOLOGIES INC | 53,299 | $2.2M | 1.6% |
| HRMY HARMONY BIOSCIENCES HLDGS IN | 27,049 | $984.9K | 0.7% |
| INSM INSMED INC | 6,580 | $701.6K | 0.5% |
| ETHA ISHARES ETHEREUM TR | 50,549 | $601.0K | 0.5% |
| IBIT ISHARES BITCOIN TRUST ETF | 15,968 | $531.6K | 0.4% |
| CHIME FINL INC | 21,075 | $431.6K | 0.3% |
| RANI RANI THERAPEUTICS HLDGS INC | 493,584 | $375.3K | 0.3% |
| TRDA ENTRADA THERAPEUTICS INC | 49,082 | $361.2K | 0.3% |
| BOLT BOLT BIOTHERAPEUTICS INC | 5,000 | $19.2K | <0.1% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 1 in all · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| CHIME FINL INC | 21,075 | $431.6K | 0.3% |
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| CYBIN INC | 460,000 | 987,222 | +114.6% | $6.5M |
Decreases
| Holding | Shares 2026-03-31 | Shares 2026-06-30 | Change | Reported value |
|---|---|---|---|---|
| OCS OCULIS HOLDING AG | 350,745 | 300,565 | -14.3% | $4.2M |
| BOLT BOLT BIOTHERAPEUTICS INC | 29,250 | 5,000 | -82.9% | $19.2K |
CIK 1782539 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
